AI Is The New Electricity
The evolution of data and digital health uses in both the healthcare and research worlds is bringing the two closer together for the good of patients.
Michael Ibara, Chief Data Officer, Elligo Health Research, discusses the history of mining healthcare data and using it to identify safety events, as well as the evolution of bringing EHR data closer to the clinical research worlds. Ibara also touches on the implications of AI—comparing its fundamental impact as “the new electricity”—and its potential uses for clinical trials, regulatory, and the ethics around large language models.
About the speaker
Michael Ibara, Chief Data Officer, Elligo Health Research, has more than 20 years of experience in clinical research and development. His interests include regulatory and policy implications for digital healthcare. Before joining Elligo, he was the Head of Digital Healthcare for the Clinical Data Interchange Standards Consortium. Michael also has experience as Head of Business Development Coordination and Innovation and also Head of Pharmacovigilance Innovation at Pfizer, where he worked for 15 years in various positions.
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
